Filter Results
:
(2,384)
Show Results For
-
All HBS Web
(2,384)
- People (4)
- News (532)
- Research (1,440)
- Events (10)
- Multimedia (31)
- Faculty Publications (940)
Show Results For
-
All HBS Web
(2,384)
- People (4)
- News (532)
- Research (1,440)
- Events (10)
- Multimedia (31)
- Faculty Publications (940)
V. Kasturi Rangan
Kash Rangan is the Malcolm P. McNair Professor of Marketing at the Harvard Business School. Formerly the chairman of the Marketing Department (1998-2002), he is now the co-chairman of the school's Social Enterprise Initiative. He has taught in a wide variety of MBA... View Details
- January 1996
- Case
Palm Computing, Inc. (A)
By: Myra M. Hart
Discusses patents, licenses, and deal making in a start-up venture. The entrepreneur, Jeff Hawkins, holds a patent on Palm Print, a pattern recognition algorithm. After licensing Palm Print to his employer, he led three years of development of commercial products for...
View Details
Keywords:
Intellectual Property;
Patents;
Agreements and Arrangements;
Negotiation Deal;
Business Startups;
Management Teams
Hart, Myra M. "Palm Computing, Inc. (A)." Harvard Business School Case 396-245, January 1996.
- 2022
- Working Paper
How Do Copayment Coupons Affect Branded Drug Prices and Quantities Purchased?
By: Leemore S. Dafny, Kate Ho and Edward Kong
Drug copayment coupons to reduce patient cost-sharing have become nearly ubiquitous for high-priced brand-name prescription drugs. Medicare bans such coupons on the grounds that they are kickbacks that induce utilization, but they are commonly used by...
View Details
Keywords:
Prescription Drugs;
Coupons;
Impact;
Health Care and Treatment;
Markets;
Price;
Spending;
Pharmaceutical Industry;
United States
Dafny, Leemore S., Kate Ho, and Edward Kong. "How Do Copayment Coupons Affect Branded Drug Prices and Quantities Purchased?" NBER Working Paper Series, No. 29735, February 2022.
- November 2023
- Case
Tata Group in 2021: Pursuing Profits through Purpose
By: Tarun Khanna, Krishna G. Palepu and Vidhya Muthuram
October 8, 2021: Tata Sons won a bid to acquire India’s national carrier Air India, marking the airline's return to its original owners after 68 long years. The winning bid of $2.4 billion gave Tata Sons full ownership of the airline and its coveted network of 6,200...
View Details
- 15 Apr 2023
- Conference Presentation
Autonomous Systems
By: Hise O. Gibson, Rob Wittman, Brandon Tseng, Nini Hamrick and Tim Booher
Autonomous systems have been on the front lines and front pages in the war in Ukraine, yet there are many unanswered questions regarding their future role and capabilities. Currently, these systems are employed in myriad use cases in logistics, intelligence, and...
View Details
- June 1994 (Revised February 1999)
- Case
Marcia Radosevich and Health Payment Review--1989 (A)
Martha Radosevich, president of Health Payment Review, a small software start-up, confronts a serious cash-flow problem: Health Payment Review has built a PC-based prototype but has run out of funds to build a commercially acceptable mainframe product. As a stop-gap...
View Details
Keywords:
Negotiation;
Cash Flow;
Entrepreneurship;
Applications and Software;
Sales;
Information Technology Industry
Bhide, Amar. "Marcia Radosevich and Health Payment Review--1989 (A)." Harvard Business School Case 394-204, June 1994. (Revised February 1999.)
- August 2009 (Revised March 2011)
- Case
Shenzhen Development Bank
By: Li Jin, Yuhai Xuan and Xiaobing Bai
Weijian Shan, Managing Partner of Newbridge Capital, faces a tough call in regard to his firm's investment in Shenzhen Development Bank, China's fifteenth-largest commercial bank listed on the Shenzhen Stock Exchange. Due to the aggressive lobby of the existing...
View Details
Keywords:
Mergers and Acquisitions;
Private Equity;
Commercial Banking;
Investment;
Emerging Markets;
Business and Government Relations;
Banking Industry;
China
Jin, Li, Yuhai Xuan, and Xiaobing Bai. "Shenzhen Development Bank." Harvard Business School Case 210-020, August 2009. (Revised March 2011.)
- December 2008 (Revised October 2013)
- Case
Amylin Pharmaceuticals: Diabetes and Beyond (A)
By: Richard G. Hamermesh and Rachel Gordon
Ginger Graham, CEO of Amylin Pharmaceuticals, joined the company with the expectation of taking the company's signature drug, Symlin, to market. However, unforeseen regulatory challenges have put the approval process in jeopardy. At the same time, the company has a...
View Details
Keywords:
Regulations;
Drug Regulations;
Symlin;
Negotiation;
Governing Rules, Regulations, and Reforms;
Resource Allocation;
Negotiation Deal;
Product Development;
Research and Development;
Commercialization;
Pharmaceutical Industry;
United States
Hamermesh, Richard G., and Rachel Gordon. "Amylin Pharmaceuticals: Diabetes and Beyond (A)." Harvard Business School Case 809-011, December 2008. (Revised October 2013.)
- April 1998
- Case
Cephalon, Inc.
By: Peter Tufano
In early 1997, Cephalon, awaited an FDA panel's decision on whether its drug, Myotrophin, would be approved. If the drug was approved, the firm might need substantial additional funds to commercialize as well as to buy back rights to it (which had been sold earlier to...
View Details
Keywords:
Risk Management;
Financing and Loans;
Health Care and Treatment;
Pharmaceutical Industry;
United States
Tufano, Peter, Geoffrey Verter, and Markus Mullarkey. "Cephalon, Inc." Harvard Business School Case 298-116, April 1998.
- August 2007 (Revised October 2022)
- Case
Ken Durham and Unilever as a 'Multi-Local Multinational'
By: Geoffrey Jones and Stephanie Decker
Explores the opportunities and threats to Unilever's global business in 1978 based on the commercial and political challenges faced by three of its subsidiaries, Lever Brothers in the United States, Hindustan Lever in India, and United Africa Company in West Africa....
View Details
Keywords:
Business Divisions;
Local Range;
Global Strategy;
Multinational Firms and Management;
Management Style;
Competitive Strategy;
Africa;
India;
United States
Jones, Geoffrey, and Stephanie Decker. "Ken Durham and Unilever as a 'Multi-Local Multinational'." Harvard Business School Case 808-025, August 2007. (Revised October 2022.)
- 2019
- Working Paper
Who Drives Digital Innovation? Evidence from the U.S. Medical Device Industry
By: Cirrus Foroughi and Ariel Dora Stern
Does the large-scale technological change that is characteristic of an industry-wide digital transformation entrench industry leaders or enable the rise of new entrants? We offer a novel approach to this question by studying the medical device industry, a unique...
View Details
Keywords:
Innovation;
Medical Devices;
Digitization;
Medical Technology;
Technological Innovation;
Applications and Software;
Market Entry and Exit;
Industry Growth;
Medical Devices and Supplies Industry;
United States
Foroughi, Cirrus, and Ariel Dora Stern. "Who Drives Digital Innovation? Evidence from the U.S. Medical Device Industry." Harvard Business School Working Paper, No. 19-120, June 2019.
- 2013
- Working Paper
How the Zebra Got Its Stripes: Imprinting of Individuals and Hybrid Social Ventures
By: Matthew Lee and Julie Battilana
Hybrid organizations that combine multiple, existing organizational forms are frequently proposed as a source of organizational innovation, yet little is known about the origins of such organizations. We propose that individual founders of hybrid organizations acquire...
View Details
Keywords:
Hybrid Organizations;
Imprinting;
Institutional Theory;
Social Entrepreneurship;
Organizations
Lee, Matthew, and Julie Battilana. "How the Zebra Got Its Stripes: Imprinting of Individuals and Hybrid Social Ventures." Harvard Business School Working Paper, No. 14-005, July 2013.
How Do Drug Copayment Coupons Affect Branded Drug Prices and Quantities Purchased?
Drug copayment coupons to reduce patient cost-sharing have become nearly ubiquitous for high-priced brand-name prescription drugs. Medicare bans such coupons on the grounds that they are kickbacks that induce utilization, but they are commonly used by...
View Details
- September 2023
- Case
To Found or to Cofound? That is the Question
By: Christina Wallace and Jo Tango
Entrepreneurs often struggle with the question of whether to found solo or alongside one or more cofounders. This case is comprised of three vignettes detailing common founding scenarios: the first-time technical founder; the serial commercial founder; and the MBA...
View Details
Wallace, Christina, and Jo Tango. "To Found or to Cofound? That is the Question." Harvard Business School Case 824-034, September 2023.
- Web
Online Finance & Accounting Courses | HBS Online
What Learners are Saying Operating in general management, I need to make decisions utilizing the principles we learned on a daily basis. The course empowers me to do so with confidence. Paul AccorneroInternational Commercial Director...
View Details
- March 2022
- Article
Loan Types and the Bank Lending Channel
By: Victoria Ivashina, Luc Laeven and Enrique Moral-Benito
Using credit-registry data for Spain and Peru, we document that four main types of commercial credit—asset-based loans, cash flow loans, trade finance and leasing—are easily identifiable and represent the bulk of corporate credit. We show that credit growth dynamics...
View Details
Keywords:
Bank Credit;
Loan Types;
Bank Lending Channel;
Credit Registry;
Banks and Banking;
Credit;
Financing and Loans
Ivashina, Victoria, Luc Laeven, and Enrique Moral-Benito. "Loan Types and the Bank Lending Channel." Journal of Monetary Economics 126 (March 2022): 171–187.
- October 2005
- Case
Kinko's
Over the decades, Kinko's had forged a deep emotional bond with consumers by easing their anxiety and helping them solve pressing document processing problems. By 2003, however, consumer research revealed that a confusing retail experience had eroded some of this good...
View Details
- June 1994 (Revised March 1995)
- Background Note
New Product Commercialization: Common Mistakes
Addresses the common mistakes made in new product development and launch. Many times customers' and suppliers' perceptions of the degree of product/market innovation do not match. One of them may view the innovations as a "breakthrough," but the other may view it only...
View Details
Rangan, V. Kasturi. "New Product Commercialization: Common Mistakes." Harvard Business School Background Note 594-127, June 1994. (Revised March 1995.)
- August 2022
- Case
In-Q-Tel: Innovation On A Mission
By: Joshua Lev Krieger and Josh Lerner
In 2022, the leaders of In-Q-Tel (IQT) considered what was next for the unique mission-driven organization. Since 1999, IQT had one mission: to be the most sophisticated source of strategic technical knowledge and capabilities to the U.S. government and its allies. IQT...
View Details
Keywords:
Mission and Purpose;
National Security;
Technological Innovation;
Research;
Geopolitical Units;
Risk Management;
Recruitment;
Growth and Development Strategy;
Venture Capital;
Knowledge Management;
Information Industry;
Banking Industry
Krieger, Joshua Lev, and Josh Lerner. "In-Q-Tel: Innovation On A Mission." Harvard Business School Case 823-031, August 2022.
- Article
Health as a Way of Doing Business
By: Howard Koh, Sara J. Singer and Amy C. Edmondson
For too long, the worlds of business and health have been mired in a checkered, sometimes contentious, history. Millions of deaths worldwide can be attributed to risk factors including tobacco use, alcohol and drug misuse, and suboptimal dietary intake linked to...
View Details
Koh, Howard, Sara J. Singer, and Amy C. Edmondson. "Health as a Way of Doing Business." JAMA, the Journal of the American Medical Association 321, no. 1 (January 1, 2019): 33–34.